menu toggle

Cell and Gene Therapy: Creating connections amid complexity


Product developments in cell and gene therapy are both among the most groundbreaking and the most complex.

In this interview with Fierce Biotech, Doug Cook, President Commercialization Services and Animal Health at AmerisourceBergen, talks about the cell and gene therapy landscape and explains the company's role in manufacturer offerings, from the clinical trial stage to consulting through patient support and payer strategy.